Lange Wantzin G, Thomsen K
Br J Dermatol. 1984 Jul;111(1):93-5. doi: 10.1111/j.1365-2133.1984.tb04021.x.
The effect of weekly methotrexate treatment (5 to 25 mg orally) was studied in three patients with lymphomatoid papulosis. In all three patients a good clinical effect was obtained. Skin biopsies revealed no sign of lymphomatoid papulosis after treatment. Methotrexate appears to be effective in controlling lymphomatoid papulosis and is possibly superior to PUVA in this respect.
对三名淋巴瘤样丘疹病患者进行了每周口服甲氨蝶呤（5至25毫克）治疗效果的研究。所有三名患者均获得了良好的临床效果。治疗后皮肤活检未显示淋巴瘤样丘疹病迹象。甲氨蝶呤似乎对控制淋巴瘤样丘疹病有效，在这方面可能优于补骨脂素紫外线A光化学疗法（PUVA）。
